SLNO Latest Press Releases

-- February 26, 2026 --

Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer Globe Newswire 8:00 AM

-- February 25, 2026 --

Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT XR Globe Newswire 4:10 PM

-- February 11, 2026 --

Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET Globe Newswire 8:00 AM

-- January 29, 2026 --

Soleno Therapeutics to Participate in Upcoming Conferences Globe Newswire 8:00 AM

-- January 20, 2026 --

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses Globe Newswire 9:27 AM

-- January 16, 2026 --

SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation Globe Newswire 8:00 PM

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman Globe Newswire 12:36 PM

-- January 12, 2026 --

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc. Business Wire 6:00 PM

Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results Globe Newswire 7:00 AM

-- January 9, 2026 --

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP Globe Newswire 6:00 PM

-- January 8, 2026 --

Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations Globe Newswire 5:00 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 10:00 AM

-- January 5, 2026 --

Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT XR in the Journal of Clinical Endocrinology and Metabolism Globe Newswire 8:00 AM

-- January 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 10:00 AM

-- December 30, 2025 --

Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) Business Wire 8:00 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO Globe Newswire 4:50 PM

-- December 16, 2025 --

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses PRNewswire 12:21 PM

-- December 11, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 10:00 AM

-- December 4, 2025 --

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses PRNewswire 5:23 PM

-- December 3, 2025 --

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations Globe Newswire 4:51 PM

Soleno Therapeutics Announces the Passing of Board Member William G. Harris Globe Newswire 4:05 PM

-- December 1, 2025 --

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses Globe Newswire 5:48 PM

-- November 24, 2025 --

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses Globe Newswire 12:03 PM

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:00 AM

-- November 20, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 10:00 AM

-- November 18, 2025 --

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations Globe Newswire 5:22 PM

-- November 16, 2025 --

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm Globe Newswire 5:05 PM

-- November 14, 2025 --

SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law Globe Newswire 10:05 AM

-- November 13, 2025 --

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% - Hagens Berman Globe Newswire 12:17 PM

-- November 12, 2025 --

Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm Globe Newswire 10:56 AM

-- November 11, 2025 --

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses Globe Newswire 1:05 PM

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement Globe Newswire 7:00 AM

SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm Business Wire 7:00 AM

-- November 10, 2025 --

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm Globe Newswire 5:22 PM

-- November 7, 2025 --

SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm PRNewswire 7:30 PM

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman PRNewswire 10:04 AM

-- November 6, 2025 --

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman Globe Newswire 2:38 PM

-- November 4, 2025 --

Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR Globe Newswire 4:01 PM

-- October 30, 2025 --

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO Business Wire 5:00 PM

-- October 28, 2025 --

Soleno Therapeutics to Participate in Upcoming November Conferences Globe Newswire 8:00 AM

-- October 27, 2025 --

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 9:41 PM

-- October 21, 2025 --

Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET Globe Newswire 8:00 AM

-- October 20, 2025 --

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO PRNewswire 9:12 PM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 10:00 AM

-- October 13, 2025 --

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO PRNewswire 8:00 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 2:01 PM

Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors Globe Newswire 8:00 AM

-- October 9, 2025 --

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman Globe Newswire 1:47 PM

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm Globe Newswire 12:35 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 5:45 PM

-- October 5, 2025 --

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNO PRNewswire 3:00 PM

-- October 3, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO PRNewswire 10:00 AM